Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
ASAP Trial Finds No Benefit for Pre-Transplant Chemotherapy in AML
November 2025
The ASAP trial shows immediate transplantation matches chemotherapy outcomes in AML, with genetics driving survival differences.
Read more
9
Mins
1 Aug 2019
Eltrombopag-Induced Myelofibrosis in Patients with Adult Immune Thrombocytopenia: Scoping Review
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder that lessens the production of platelets. Despite treatments being available for ITP…
5
Mins
1 Aug 2019
Resistant Bilateral Chylous Effusion as a Late Adverse Effect of Dasatinib Treatment in Chronic Myeloid Leukaemia
Dasatinib is a potent and efficacious second-generation oral tyrosine kinase inhibitor, frequently used for imatinib-resistant or intolerant BCR-ABL+…
5
Mins
1 Aug 2019
Are Successful Pregnancies an Achievable Goal in Patients with Chronic Myeloid Leukaemia?
Currently, there is no evidence-based consensus for the management of CML in pregnancy; therefore, clinical observations have become very important…
8
Mins
1 Aug 2019
A Review of the Different Haematological Parameters and Biomarkers Used for Diagnosis of Neonatal Sepsis
Even though there are recent sophisticated biomarkers to diagnose sepsis, it is still challenging to curtail sepsis mortality by timely intervention…
18 Jun 2019
Essential Medicines Shortage: The New Call to Action
A collective Call to Action has been issued to the European Union (EU) by the European Society for Medical Oncology (ESMO) and endorsed by the European…
18 Jun 2019
Promising Results from Sickle Cell Disease Bone Marrow Transplant Pilot Study
Bone marrow transplantation was the subject of a recent pilot study investigating a prophylactic regimen both for matched sibling donors and unrelated…
9
Mins
8 Apr 2019
Expectations and Experience: Optimising Efficacy and Maintaining Quality of Life in Follicular Lymphoma
Prof Salles provided an update on the ongoing first-line follicular lymphoma (FL) studies, demonstrating how analysis of the GALLIUM study data regarding…
26 Feb 2019
The Double Life of p53, the Guardian of the Genome
WIDELY understood as a suppressor of cancer development, earning it the nickname ‘the guardian of the genome’, the protein p53 may, in fact, also promote…
Loading posts...
« Previous
1
…
70
71
72
73
74
…
95
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View